background: SYCP3 mutations have been shown to generate an aberrant synaptonemal complex in a dominant-negative manner and to contribute to abnormal chromosomal behavior that might lead to recurrent miscarriage. We examined whether SYCP3 mutation is associated with recurrent miscarriage caused by embryonic aneuploidy.
Introduction
SYCP3 mutations in women were found to generate an aberrant synaptonemal complex in a dominant-negative manner and to contribute to abnormal chromosomal behavior that might lead to recurrent miscarriage (Bolor et al., 2009) . Bolor et al. (2009) found SYCP3 mutations in 2 of 26 (7.7%) patients with recurrent miscarriage. SYCP3 is a DNA-binding protein and a structural component of the synaptonemal complex, which mediates the synapsis or homologous pairing of chromosomes during meiosis of the germ cells. Male mice homozygous for the null mutation of the Sycp3 gene are sterile as a result of massive apoptotic cell death in the testis during meiotic prophase (Yuan et al., 2000) . Sycp3-deficient female mice are subfertile with a severely reduced oocyte pool. Although two-thirds of mouse offspring are healthy, one-third is affected by aneuploidy and succumbs during development in utero (Yuan et al., 2002) . This is consistent with the observations that in humans, a mutation in SYCP3 was identified in two patients with azoospermia (Miyamoto et al., 2003) , and that the lack of SYCP3 gene expression in human testis may have a negative effect on spermatogenesis and male fertility (Aarabi et al., 2006) .
The identifiable causes of recurrent miscarriage may include abnormal chromosomes in either partner (particularly translocations), antiphospholipid antibodies (aPL) and uterine anomalies (Farquharson et al., 1984; Sugiura-Ogasawara et al., 2004 . A currently prevailing hypothesis is that recurrent miscarriage may be a polygenetic disorder associated with both genetic and environmental determinants. Polymorphisms related to thrombophilia, such as Leiden mutation and prothrombin mutation, are known to be associated with recurrent miscarriage, although the mutations are not found in the Asian population (Nelen et al., 1996; Rey et al., 2003; Rai and Regan, 2006; Suzumori and Sugiura-Ogasawara, 2010) . However, whether Factor V Leiden and Factor II prothrombin polymorphisms are risk factors for recurrent miscarriage is controversial Goodman et al., 2006 ). An abnormal embryonic karyotype causes not only sporadic spontaneous abortion but also recurrent miscarriage because it was found in 51% of recurrent cases (Ogasawara et al., 2000; Carp et al., 2001) . Bolor et al. (2009) could not prove an association between the SYCP3 mutations found in 7.7% of patients and embryonic aneuploidy.
Preimplantation genetic screening (PGS) for aneuploidy has been performed widely; however, there is no evidence of its ability to improve delivery rates (Platteau et al., 2005; The ACOG., 2009; Harper et al., 2010) . The SYCP3 mutation might be a candidate for selection of cases for PGS if an association between the mutation and aneuploidy is established. Also, the 7.7% frequency of SYCP3 mutation is relatively high because the frequency of translocations, aPL and major uterine anomalies is 4.5% (Sugiura- Ogasawara et al., 2004) , 10.7% (Balasch et al.,1990 ) and 3.2% (Sugiura- , respectively. Here we investigate whether SYCP3 mutations may be associated with recurrent miscarriage caused by aneuploidy.
Materials and Methods

Patients
All patients underwent a systematic examination, including hysterosalpingography, chromosome analysis for both partners, determination of aPL, including lupus anticoagulant and b2glycoprotein I-dependent anticardiolipin antibodies (Ogasawara et al., 1996) , and blood tests for hyperthyroidism, diabetes mellitus and hyperprolactinemia before subsequent pregnancy in Nagoya City University Hospital between 2007 and 2010. A blood sample was taken at the examination and frozen at 2708C before analysis. Patients with identifiable causes of miscarriage, such as translocations, aPL and uterine anomalies, were excluded. The 81 patients for whom a previous or subsequent embryonic (or fetal) karyotype was ascertained at least one time were studied. A further 20 patients for whom the embryonic karyotype was unknown were added.
In Japan, miscarriage is defined as loss within 22 weeks gestation and stillbirth is defined as loss at 22 or more weeks of gestation. Stillbirths after 22 weeks gestation were included in the present study and shown as prior history in Table I. A total of 101 patients with a history of three or more (3-16) unexplained consecutive first-trimester miscarriages were examined. Subsequent pregnancies were followed up until October 2010. The mean age of participants at examination was 34.4 + 3.8 years, and the average number of previous miscarriages was 3.8 + 2.7. Twenty-four patients had a history of live birth and two patients experienced recurrent miscarriage after changing partner, having had a live birth by a previous partner. The mean number of previous live births was 0.27 + 0.5.
Gestational age was calculated based on basal body temperature charts. Ultrasonography was performed once a week from 4 to 8 weeks of gestation. Dilation and curettage was carried out when miscarriages were diagnosed, and the karyotypes of aborted conceptuses were determined using a standard G-banding technique.
The 82 fertile women with no history of recurrent miscarriage and complications of pregnancy were examined as controls. The fertile controls were recruited in Nagoya City University Hospital and Asamoto Women's Clinic. The mean age of women in the control group was 32.3 + 6.2 years, and the average number of deliveries was 1.53 + 0.6.
The study was approved by the Research Ethics Committee of Nagoya City University Graduate School of Medical Sciences. Each patient provided their written consent after full disclosure about the purpose and methods to be employed.
DNA analysis
Genomic DNA was extracted from peripheral blood samples with the Midi Blood DNA Extraction kit (Qiagen, Tokyo, Japan). Oligonucleotide primers were designed to amplify each coding sequence, as well as exon -intron boundaries of the human SYCP3 gene, encompassing exons 7 -9 (GenBank accession number NM_153694). The sense and antisense PCR and sequence primers for SYCP3 were, respectively, 5
′ -GATGGCGTG TGCCTATAATCCAAG-3 ′ and 5 ′ -CGTCTTTATTTAATTGACAGTGT TAG-3 ′ . Additional direct sequence primers were 5
′ . The coding exons 7 -9 and exon-intron boundaries of human SYCP3 gene were amplified by PCR and sequenced using the Big Dye Terminator v3.1 Cycle Sequencing kit (ABI Prism, Applied Biosystems, Foster City, CA, USA) on a 3100 automated sequencer.
Results
Heterozygous 657T.C mutation in exon 8 of SYCP3 was ascertained in one of 101 patients who had had six recurrent miscarriage and in one of the 82 fertile controls (Fig. 1) . The IVS7-16_19 delACTT previously reported in one patient with recurrent miscarriage or 643delA previously reported in two patients with azoospermia was not found in any patients with recurrent miscarriage or in fertile controls. No other new mutation was found in patients with recurrent miscarriage or controls.
Thirty-two patients experienced miscarriage with a normal embryonic (fetal) chromosome karyotype, and 47 patients presented an abnormal embryonic (fetal) karyotype (Table I) . Two patients had miscarriages with both normal and abnormal karyotype.
Patient No. 77 with the 657T.C mutation was 31 years old and experienced a total of six miscarriages and no live birth. Available fetal karyotypes were shown as 46, XX and 46, XY. The control with the 657T.C mutation had a history of one live birth and no miscarriage.
Nine patients (No. 39 -47) had repeated miscarriage with an abnormal karyotype, and seven patients (No. 75-81) had repeated miscarriage with a normal karyotype. Only 2 out of 18 (11.1%) patients had experienced miscarriages with both abnormal and normal embryonic karyotypes.
Discussion
In the present study, we found a heterozygous 657T.C mutation in exon 8 of the SYCP3 gene in one patient and one fertile control. We could not find the IVS7-16_19 delACTT reported in one patient with recurrent miscarriage or 643delA reported in two patients with azoospermia in any patients with recurrent miscarriage or in fertile controls (Miyamoto et al., 2003; Bolor et al., 2009) . No other new mutation was found in patients with recurrent miscarriage or controls. Bolor et al. (2009) reported that 7.7% (2 of 26) patients with unexplained recurrent miscarriage were found to carry independent heterozygous nucleotide alterations, IVS7-16_19delACTT and 657T.C in SYCP3, neither of which was present among a control group of 150 fertile women. They also reported that analysis of transcripts from minigenes harboring each of these two mutations revealed that both mutations affected normal splicing, possibly resulting in the *ND, not detected; **NT, not tested; ***Live birth, He is 8 years old; Pt., patient; P.M., previous miscarriage; L.V., Live Birth; Bio Misc, biochemical miscarriage, decreasing hCGs , 1500 mIU/ml; age, age at examination karyotype; a, aneuploidy; n, normal karyotype (euploidy) from Pt. 1-81, karyotype were knowed in proir history or subsequent pregnancy; 'Outcome' reflect the conclusion of subsequent pregnancy; 's' means success in live birth delivery; 'f' means failure, miscarriage.
production of proteins that were mutated at the C-terminus. However, the effects of the SYCP3 mutations on non-disjunction or the function of the synaptonemal complex have not been clear in mammals so far. Our patient with 657T.C had repeated miscarriages with euploidy. It may be that the 657T.C mutation is a polymorphism without the specific function ascertained in the Bolor et al. (2009) study in humans. Further studies with larger numbers and a wide range of cases are needed to define whether the SYCP3 mutations can be a cause of recurrent miscarriage.
Sycp3-deficient mice show complete meiotic arrest leading to male infertility (Yuan et al., 2000) . Miyamoto et al. (2003) identified in two azoospermia patients a 1 bp deletion of the SYCP3 gene (643delA) that results in a premature stop codon and truncation of the Cterminal, coiled-coil-forming region of the SYCP3 protein. The mutant protein showed greatly reduced interaction with the wild-type protein in vitro (Miyamoto et al., 2003) . Reynolds et al. (2007) suggested that azoospermia associated with a decrease in the DAZ gene function in humans might, in part, be the consequence of failure at synapsis caused by reduced levels of the SYCP protein.
However, no female patient with the 643delA mutation of SYCP3 has been reported. The infertile women might have the mutation because embryos with trisomy or monosomy except 45,X are frequently seen by PGD.
Our data showed that among the normal fetal karyotypes, XX and XY were found at a similar frequency, indicating that fetal rather than maternal karyotypes were obtained. In this study, about 90% of patients with abnormal and normal embryonic (fetal) karyotype tended to have repeat miscarriages with abnormal and normal karyotypes, respectively. The results suggest that unexplained recurrent miscarriage should be grouped as two types: one is miscarriage caused by abnormal embryonic karyotype and the other is 'real' unexplained recurrent miscarriage.
Moreover, the prognosis of a successful pregnancy for patients with an abnormal embryonic karyotype was better than for patients with a normal embryonic karyotype (Ogasawara et al., 2000) . No therapeutic approach to improve the rate of live birth could be found at this time (Kaandorp et al., 2010) . Thus, the gene associated with unexplained recurrent miscarriage with normal embryonic karyotype is more important (Suzumori and Sugiura-Ogasawara, 2010) .
The results of our study suggest no clinical significance of routine screening for the presence of the SYCP3 mutation in women with recurrent miscarriage because we detected only one benign mutation in 101 such patients. Future studies in mammalian animal models are likely to accelerate our understanding of the molecular mechanisms involved in recurrent miscarriage and will provide additional candidate genes to be screened in recurrent miscarriage patients and embryos with genetic factors. SYCP3 mutation not associated with recurrent miscarriage
